In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Adams Respiratory Therapeutics nets $106.6mm with IPO

Executive Summary

Specialty drug company Adams Respiratory Therapeutics (formerly Adams Laboratories) has netted $106.6mm with its initial public offering of 6.9mm common shares at $17. Selling shareholders also offered 2.25mm shares.
Deal Industry
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

Advertisement
UsernamePublicRestriction

Register